ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2156 • 2016 ACR/ARHP Annual Meeting

    IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes

    Kenta Kaneshiro1, Teppei Hashimoto2, Kohsuke Yoshida1, Ayako Nakai1, Naonori Hashimoto1, Kohjin Suzuki1, Koto Uchida1, Yoshiko Kawasaki2, Natsuko Nakagawa3, Nao Shibanuma4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 4Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose:   Iinterleukin(IL)-6 and tumor necrosis factor(TNF)-α play important roles in the pathogenesis of RA, however, it remains unclear how they affect or modulate the…
  • Abstract Number: 2157 • 2016 ACR/ARHP Annual Meeting

    Share the Fate: Fibroblast-like Synoviocyte Cell-to-Cell Organelle Transfer Is Directed By the Inflammatory Microenvironment

    Ruth Byrne1, Isabel Olmos Calvo2, Thomas Karonitsch3, Felix Kartnig4, Johannes Holinka5, Günter Steiner6, Peter Ertl7, Josef Smolen8 and Hans Peter Kiener9, 1Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria, 2Nanotechnology, Austrian Institute for Technology, Vienna, Austria, 3Internal Medicine III, Vienna Medical University, Vienna, Austria, 4Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 5Department of Orthopaedics, Medical University of Vienna, Vienna, Austria, 6Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 7Vienna University of Technology, Vienna, Austria, 8Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 9Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Fibroblast-like synoviocytes (FLS) form a complex tissue network via long-distance intercellular connections with wide intercellular matrix spaces. The adaptive synovial tissue response to inflammation…
  • Abstract Number: 2158 • 2016 ACR/ARHP Annual Meeting

    Serum Uric Acid Is Positively Associated with Pulmonary Function in Korean Health Screening Examinees: A Cross-Sectional Study

    Joong Kyong Ahn1, Jiwon Hwang2, Jae-Uk Song3, Hyemin Jeong4, Ji Young Chae5, Hyungjin Kim4, Hoon-Suk Cha4 and Eun-Mi Koh4, 1Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Department of Medicine, National Police Hospital, Seoul, Korea, The Republic of, 3Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, The Republic of, 4Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5Departement of Internal Medicine, Bundang Jesaeng General Hospital, Seongnam, Korea, The Republic of

    Background/Purpose: Serum uric acid (SUA) has been shown to be a powerful endogenous antioxidant in the body. The double-edged characteristics of serum uric acid (SUA)…
  • Abstract Number: 2159 • 2016 ACR/ARHP Annual Meeting

    Allopurinol Use Is Associated with Lower Risk of Peripheral Vascular Disease in the US Elderly

    Jasvinder A. Singh1 and John Cleveland2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL

    Background/Purpose: Gout is associated with higher cardiovascular disease risk. Based on our previous work, there is evidence that allopurinol use reduces the risk of myocardial…
  • Abstract Number: 2160 • 2016 ACR/ARHP Annual Meeting

    Allopurinol Use and the Risk of Acute Cardiovascular Events in Patients with Gout and Diabetes

    Jasvinder A. Singh1, Rekha Ramachandaran2 and Jeffrey Curtis3, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To examine the effect of allopurinol on the risk of incident myocardial infarction (MI) or stroke in patients with gout and diabetes Methods: We…
  • Abstract Number: 2161 • 2016 ACR/ARHP Annual Meeting

    Association Between Inflammation and Systolic Blood Pressure at Normal and High C-Reactive Protein Levels

    Zhi Yu1, Kathleen Vanni2, Seoyoung C. Kim3, Daniel H. Solomon4, Shawn N. Murphy5 and Katherine Liao6, 1Rheumatology Immunology & Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Immunology and Allergy; Pharmacoepidemiologyand Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Research Computing, Partners Healthcare Systems, Boston, MA, 6Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: While inflammation is linked with higher blood pressure (BP) in the general population, few studies have examined this relationship in patients with elevated levels…
  • Abstract Number: 2162 • 2016 ACR/ARHP Annual Meeting

    Frequent Discussion of Insomnia and Weight Gain with Glucocorticoid Therapy: An Analysis of Twitter Posts

    Rikesh Patel1, Nabarun Dasgupta2, Maksim Belousov3, Meghna Jani4, Carly Winokur2, Goran Nenadic3 and William G Dixon1,5, 1Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, 2Epidemico Inc., Boston, MA, 3School of Computer Sciences, The University of Manchester, Manchester, United Kingdom, 4Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom, 5Manchester Academic Health Sciences Centre, Health e-Research Centre, Farr Institute for Health Informatics Research, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Glucocorticoid (GC) therapy is used widely in patients with inflammatory diseases. However their effectiveness is offset by a range of potential harms. Clinicians and…
  • Abstract Number: 2163 • 2016 ACR/ARHP Annual Meeting

    Depressive Symptoms in Patients Consulting for the First Time at the Division of Rheumatology

    Cristian Troitiño1, Anastasia Secco2, Marta Mamani3, Priscila Marcaida3, Santiago Scarafia4, Vanesa Duarte5, Virginia Durigan6, Geraldyn Calizaya7, Jorgelina Lares1 and Veronica Sandoval8, 1Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, 2Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina, 4Hospital Bernardino Rivadavia, CABA, Argentina, 5Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 6Reumatology, Hospital Bernardino Rivadavia, Ciudad autonoma de buenos aires, Argentina, 7Reumatology, Hospital Bernardino Rivadavia, ciudad autonoma de buenos aires, Argentina, 8Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina

    Background/Purpose: Depression can easily go unnoticed in routine clinical care. The delay in the diagnosis may increase the risk of chronicity, the number of visits,…
  • Abstract Number: 2164 • 2016 ACR/ARHP Annual Meeting

    Depression and the Risk of Psoriatic Arthritis Among Patients with Psoriasis: A Population-Based Cohort Study

    Ryan Lewinson1,2, Isabelle Vallerand1,3, Mark Lowerison3, Laurie Parsons4, Alexandra Frolkis1,3, Gilaad Kaplan3,4, Andrew Bulloch3,5,6, Scott Patten3,5 and Cheryl Barnabe3,4, 1Leaders in Medicine Program, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Biomedical Engineering Program, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, 3Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 6Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Depression and the Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Cohort Study Background/Purpose: The factors that contribute to the development of psoriatic…
  • Abstract Number: 2165 • 2016 ACR/ARHP Annual Meeting

    Natural Language Processing to Rapidly Identify Potential Signals for Adverse Events Using Electronic Medical Record Data: Example of Arthralgias and Vedolizumab

    Tianrun Cai1, Gwendolyn Kane-Wanger2, Allison Bond3, Andrew Cagan4, Shawn N. Murphy5, Ashwin Ananthakrishnan6 and Katherine Liao1, 1Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Boston, MA, 3Medicine, Massachusetts General Hospital, Boston, MA, 4Research Computing, Partners HealthCare, Charlestown, MA, 5Neurology, Massachusetts General Hospital, Boston, MA, 6Internal Medicine, Massachusetts General Hospital, Boston, MA

    Natural language processing to rapidly identify potential signals for adverse events using electronic medical record data: example of arthralgias and vedolizumab Background/Purpose: In our rheumatology…
  • Abstract Number: 2166 • 2016 ACR/ARHP Annual Meeting

    Inflammatory Arthropathy and Hashimoto’s Thyroiditis: Prevalence and Associated Factors

    Eliangel J García-Carrión1, Luis M Valderrama-Hinds1, Evelyn Hernandez2, Maria Isabel Agostini2, Omar R Reyes Morales3, Soham Al Snih4, Liliana Fung2 and Martín A Rodríguez5,6, 1Rheumatology, Hospital Universitario de Caracas, Caracas, Venezuela (Bolivarian Republic of), 2Endocrinology, Hospital Universitario de Caracas, Caracas, Venezuela (Bolivarian Republic of), 3Philosophy of science, Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of), 4University of Texas Medical Branch, Galveston, TX, 5Centro Nacional de Enfermedades Reumáticas, Caracas, Venezuela, 6Rheumatology, Hospital Universitario de Caracas, Caracas, Venezuela

    Background/Purpose:  Patients with Hashimoto´s thyroiditis (HT) are frequently seen by rheumatologists due to rheumatic complain that do not fit into diagnostic criteria for a definite…
  • Abstract Number: 2167 • 2016 ACR/ARHP Annual Meeting

    Validation of the Earp Questionnaire: Detection of Psoriatic Arthritis in the Spanish Population

    juan garcia Gavin1, Ceferino Barbazan1, Rafael Botella2, Jose Andres Roman3, david vidal4, Delia Reina4, Antonio Javier Chaves5, Jose Luis Alvarez5, Antonio Velez6, Maria Dolores Lopez Montilla6, Javier Mataix7, Jose Rosas7, Ricardo Ruiz Villaverde8, Rafael Caliz8, Miren Alustiza9 and Virginia Carrasco9, 1Complejo Universitario Hospitalario de Vigo, Vigo, Spain, 2Hospital Universitario y Politécnico La Fe, Valencia, Spain, 3Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain, 4Hospital de Sant Joan Despí Moisés Broggi, Barcelona, Spain, 5Hospital Infanta Cristina de Badajoz, Badajoz, Spain, 6Hospital Reina Sofía, Cordoba, Spain, 7Hospital de la Marina Baixa de Villajoyosa, Alicante, Spain, 8Hospital Virgen de las Nieves, Granada, Spain, 9Abbvie, Madrid, Spain

    Background/Purpose: Psoriatic arthritis (PsA) is a progressive, debilitating condition. It is estimated that between 25 and 35% of patients with psoriasis may develop psoriatic arthritis…
  • Abstract Number: 2168 • 2016 ACR/ARHP Annual Meeting

    Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases

    Marco Antivalle1,2, Valentina Varisco2, Alessandra Mutti2, Alberto Batticciotto2, Maria Chiara Ditto2, Fabiola Atzeni3 and Piercarlo Sarzi-Puttini2, 1Rheumatology, Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 3Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy

    Background/Purpose:  all-cause and cardiovascular mortality and cardiovascular morbidity are reportedly increased in rheumatic diseases, both inflammatory and non-inflammatory. Few studies, however have addressed the impact…
  • Abstract Number: 2169 • 2016 ACR/ARHP Annual Meeting

    Presence of Cardiovascular Risk Factors Across Different Inflammatory Joint Disease Entities: Results from a Norwegian, Multi-Centre Project

    Grunde Wibetoe1, Eirik Ikdahl2, Silvia Rollefstad2, Anne Salberg3, Dag Magnar Soldal4, Tore K Kvien5, Glenn Haugeberg6 and Anne Grete Semb7, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Diakonhjemmet Hospital, Oslo, Norway, 3Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, 5Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Martina Hansens Hospital, Bærum, Norway, 7Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: EULAR recommendations for cardiovascular disease (CVD) risk management in inflammatory joint diseases (IJD) advocates annual CVD risk assessments to reduce the increased CVD risk.…
  • Abstract Number: 2170 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom

    Ernest H. Choy1, Roxanne Cooksey2, Sinead Brophy2, Jonathan Kennedy2, Fabiola Fernandez-Gutierrez3, Ruth Davies4, Timothy Pickles5 and Vincent Piguet6, 1CREATE Center, Division of Infection and Immunity,, Cardiff University, Cardiff, United Kingdom, 2College of Medicine, Swansea University, Swansea, United Kingdom, 3Cancer Research UK Manchester Institute, Manchester, United Kingdom, 4CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 5CREATE Center, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 6Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

    Background/Purpose: Compared with cardiovascular (CV) risk in rheumatoid arthritis (RA), precise CV risk in psoriatic arthritis (PsA) and psoriasis is less established, particularly the relative…
  • « Previous Page
  • 1
  • …
  • 1559
  • 1560
  • 1561
  • 1562
  • 1563
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology